Xinfeng Yu

2.2k total citations
43 papers, 1.7k citations indexed

About

Xinfeng Yu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xinfeng Yu has authored 43 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Xinfeng Yu's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and Estrogen and related hormone effects (4 papers). Xinfeng Yu is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and Estrogen and related hormone effects (4 papers). Xinfeng Yu collaborates with scholars based in China, United States and Canada. Xinfeng Yu's co-authors include Xian‐Jun Qu, Xiaohui Wang, Shu‐Xiang Cui, Teresita Bellido, Shiyue Sun, Stavros C. Manolagas, Wenna Shi, Dong Wang, Juan Yang and Haochen Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Oncogene.

In The Last Decade

Xinfeng Yu

43 papers receiving 1.7k citations

Peers

Xinfeng Yu
Chao Gu China
Yi Luo China
Dong Guo China
Aparna Venkatraman United States
Xinfeng Yu
Citations per year, relative to Xinfeng Yu Xinfeng Yu (= 1×) peers Ju-Ming Wang

Countries citing papers authored by Xinfeng Yu

Since Specialization
Citations

This map shows the geographic impact of Xinfeng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinfeng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinfeng Yu more than expected).

Fields of papers citing papers by Xinfeng Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinfeng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinfeng Yu. The network helps show where Xinfeng Yu may publish in the future.

Co-authorship network of co-authors of Xinfeng Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinfeng Yu. A scholar is included among the top collaborators of Xinfeng Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinfeng Yu. Xinfeng Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Wenyu, et al.. (2025). Adipokines regulate the development and progression of MASLD through organellar oxidative stress. Hepatology Communications. 9(2). 7 indexed citations
2.
Zhang, Qiaoxin, et al.. (2025). Effect of compositional changes and heat treatment on microstructure and mechanical properties of gray cast iron. Journal of Materials Research and Technology. 35. 5336–5352. 2 indexed citations
3.
Song, Yujia, Xiaohui Wang, Yuqi Sun, et al.. (2024). PRDX1 inhibits ferroptosis by binding to Cullin-3 as a molecular chaperone in colorectal cancer. International Journal of Biological Sciences. 20(13). 5070–5086. 15 indexed citations
4.
Wang, Xiaohui, Dong Wang, Xiaohui Liu, et al.. (2022). CXCL12/CXCR7/β-arrestin1 biased signal promotes epithelial-to-mesenchymal transition of colorectal cancer by repressing miRNAs through YAP1 nuclear translocation. Cell & Bioscience. 12(1). 171–171. 12 indexed citations
5.
Shi, Wenna, Shuhua Wu, Shiyue Sun, et al.. (2020). SphK2 confers 5-fluorouracil resistance to colorectal cancer via upregulating H3K56ac-mediated DPD expression. Oncogene. 39(29). 5214–5227. 30 indexed citations
6.
Yu, Xinfeng, Dong Wang, Xiaohui Wang, et al.. (2019). CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p. Journal of Experimental & Clinical Cancer Research. 38(1). 32–32. 150 indexed citations
7.
Yu, Xinfeng, Wenna Shi, Yuhang Zhang, et al.. (2017). CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer. Scientific Reports. 7(1). 42226–42226. 108 indexed citations
9.
10.
Yu, Xinfeng, Aiping Luo, Yicong Liu, et al.. (2015). MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy. Molecular Cancer. 14(1). 208–208. 96 indexed citations
11.
Yu, Xinfeng, et al.. (2014). Tag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancer. Molecular Cancer. 13(1). 56–56. 15 indexed citations
12.
Yao‐Borengasser, Aiwei, Vineetha Koroth Edavana, Rosalind B. Penney, et al.. (2014). Sulfotransferase 1A1 (SULT1A1) gene expression is regulated by members of the NFI transcription factors in human breast cancer cells. BMC Clinical Pathology. 14(1). 1–1. 25 indexed citations
13.
Luo, Aiping, Xinfeng Yu, Guichang Li, et al.. (2014). Differentiation-Associated Genes Regulated by c-Jun and Decreased in the Progression of Esophageal Squamous Cell Carcinoma. PLoS ONE. 9(5). e96610–e96610. 17 indexed citations
14.
Yang, Wenzhe, Xinfeng Yu, Quanbin Zhang, et al.. (2013). Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor. Experimental Eye Research. 115. 96–105. 52 indexed citations
15.
Edavana, Vineetha Koroth, Ishwori Dhakal, Xinfeng Yu, Suzanne Williams, & Susan Kadlubar. (2012). Sulfation of 4-Hydroxy Toremifene: Individual Variability, Isoform Specificity, and Contribution to Toremifene Pharmacogenomics. Drug Metabolism and Disposition. 40(6). 1210–1215. 17 indexed citations
16.
Yu, Xinfeng, Xuemei Zhang, Ishwori Dhakal, et al.. (2012). Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells. BMC Cancer. 12(1). 29–29. 78 indexed citations
17.
Zhang, Zhi, et al.. (2011). Genetic variant in CASP3 affects promoter activity and risk of esophageal squamous cell carcinoma. Cancer Science. 103(3). 555–560. 14 indexed citations
18.
Zhou, Hong, et al.. (2011). Potential regulatory role of calsequestrin in platelet Ca2+ homeostasis and its association with platelet hyperactivity in diabetes mellitus. Journal of Thrombosis and Haemostasis. 10(1). 116–124. 12 indexed citations
19.
Yu, Xinfeng, Aiping Luo, Changchun Zhou, et al.. (2006). Differentiation-associated genes regulated by TPA-induced c-Jun expression via a PKC/JNK pathway in KYSE450 cells. Biochemical and Biophysical Research Communications. 342(1). 286–292. 13 indexed citations
20.
Mylin, Lawrence M., et al.. (1994). SIP1 is a catabolite repression-specific negative regulator of GAL gene expression.. Genetics. 137(3). 689–700. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026